BioCentury | Feb 13, 2012
Company News

Vytacera Pharma Inc., University of Minnesota deal

...The university granted newco Vytacera exclusive, worldwide rights to develop and commercialize cyanide poisoning treatment Sulfanegen...
BioCentury | Feb 10, 2012
Company News

Newco Vytacera in-licenses cyanide poisoning treatment

...California-based newco Vytacera Pharma Inc. exclusive, worldwide rights to develop and commercialize cyanide poisoning treatment Sulfanegen...
Items per page:
1 - 2 of 2